Brief: Lipella Pharmaceuticals Announces Successful Top Line Results Of Phase 2A Clinical Trial Of Lp-10
11/01/2023 12:33
Lipella Pharmaceuticals Inc LIPO.O :
* LIPELLA PHARMACEUTICALS ANNOUNCES SUCCESSFUL TOP LINE
RESULTS OF
PHASE 2A CLINICAL TRIAL OF LP-10
Source text for Eikon: ID:nPn3zKpWGa
Further company coverage: LIPO.O
Recent news on Lipella Pharmaceuticals
See all newsBrief: Lipella Pharmaceuticals Says Bankruptcy Court Approves Sale And Asset Purchase Agreement On June 4
Brief: Lipella Pharmaceuticals Inc. Files Voluntary Petitions For Relief Under Chapter 11
Brief: Lipella Pharmaceuticals Announces Positive Final Results From Phase 2a Study Of LP-10 In Oral Lichen Planus
Brief: Lipella Pharmaceuticals Announces Delisting From Nasdaq Capital Market
U.S. STOCKS ON THE MOVE-Marriott International, Coty, Carlyle Group